Exploring modified chitosan-based gene delivery technologies for therapeutic advancements
Amol D. Gholap,Harshad S. Kapare,Sakshi Pagar,Pallavi Kamandar,Deblina Bhowmik,Nikhar Vishwakarma,Sarjana Raikwar,Atul Garkal,Tejal A. Mehta,Satish Rojekar,Navnath Hatvate,Sourav Mohanto
DOI: https://doi.org/10.1016/j.ijbiomac.2024.129581
IF: 8.2
2024-01-26
International Journal of Biological Macromolecules
Abstract:One of the critical steps in gene therapy is the successful delivery of the genes. Immunogenicity and toxicity are major issues for viral gene delivery systems. Thus, non-viral vectors are explored. A cationic polysaccharide like chitosan could be used as a nonviral gene delivery vector owing to its significant interaction with negatively charged nucleic acid and biomembrane , providing effective cellular uptake. However, the native chitosan has issues of targetability, unpacking ability, and solubility along with poor buffer capability, hence requiring modifications for effective use in gene delivery. Modified chitosan has shown that the "proton sponge effect" involved in buffering the endosomal pH results in osmotic swelling owing to the accumulation of a greater amount of proton and chloride along with water. The major challenges include limited exploration of chitosan as a gene carrier, the availability of high-purity chitosan for toxicity reduction, and its immunogenicity. The genetic drugs are in their infancy phase and require further exploration for effective delivery of nucleic acid molecules as FDA-approved marketed formulations soon.
polymer science,biochemistry & molecular biology,chemistry, applied